EN | RU
EN | RU

Help Support

Back

A study reviewed alternative therapies and new drugs for FM treatment

A study reviewed alternative therapies and new drugs for FM treatment A study reviewed alternative therapies and new drugs for FM treatment
A study reviewed alternative therapies and new drugs for FM treatment A study reviewed alternative therapies and new drugs for FM treatment

What's new?

New treatment options found for treating FM in the last seven years are still under pre-clinical phase. Thus further studies are required to evaluate the safety and effectiveness of new therapeutic agents.

A musculoskeletal disorder characterised by tenderness, widespread chronic pain, and often accompanied by other comorbid conditions such as depression, anxiety, chronic fatigue is termed fibromyalgia (FM). A patent review was aimed to survey patents of new drugs and alternative therapies for FM. The new therapeutic patents on FM treatment published from 2010 to 2017 in WIPO, DERWENT, INPI, ESPANET, and USPTO reviewed. It was found that some of the therapeutic agents in pre-clinical phases has unclear clinical applicability. Some other therapeutic approaches were seen such as well-established drugs in the market in combination or drug repositioning that combines the new analgesic effects with the old side effects. Further studies on safety and efficacy of such agents should be carried out to implement them to FM treatment.

Source:

Journal The Expert Opinion on Therapeutic Patents

Article:

New drugs or alternative therapy to blurring the symptoms of fibromyalgia—a patent review

Authors:

Lucindo J. Quintans-Junior et. al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: